Inactive Instrument
CannaVEST Corp Share Price Other OTC
Stocks
US1376531018
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Other OTC
|
||
| - USD | - |
|
| 08-13 | CV Sciences, Inc., Q2 2026 Earnings Call, Aug 13, 2026 | |
| 08-13 | CV Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 2.94M 2.56M 2.42M 2.2M 4.11M 281M 4.13M 28.83M 11.15M 143M 11.03M 10.78M 457M | P/E 2024 |
-2.48x | P/E 2025 | -11.8x |
|---|---|---|---|---|---|
| Enterprise Value | 4.65M 4.05M 3.84M 3.49M 6.51M 446M 6.54M 45.69M 17.67M 227M 17.48M 17.09M 725M | EV / Sales 2024 |
0.42x | EV / Sales 2025 | 0.95x |
| Free-Float |
78.62% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: CannaVEST Corp
| Manager | Title | Age | Since |
|---|---|---|---|
Joseph Dowling
CEO | Chief Executive Officer | 68 | 30/05/2018 |
Joerg Grasser
DFI | Director of Finance/CFO | 51 | 14/03/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Joseph Dowling
BRD | Director/Board Member | 68 | 30/05/2018 |
Jamie Corroon
BRD | Director/Board Member | 56 | 20/07/2022 |
William McCorkle
BRD | Director/Board Member | 58 | 20/10/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.54% | +1.96% | +50.64% | +100.43% | 1,014B | ||
| +0.22% | +0.56% | +51.15% | +64.86% | 644B | ||
| -0.13% | +2.93% | +18.87% | +70.51% | 464B | ||
| -0.36% | +4.54% | +38.71% | +40.03% | 354B | ||
| +1.52% | +3.46% | +20.13% | +26.08% | 265B | ||
| +2.41% | +5.70% | +9.06% | +15.85% | 253B | ||
| +1.02% | -0.45% | +38.60% | +44.69% | 203B | ||
| +2.48% | -2.43% | -24.40% | -57.05% | 186B | ||
| +1.18% | +3.14% | +33.05% | +97.51% | 183B | ||
| Average | +0.98% | +0.96% | +26.20% | +44.77% | 396.31B | |
| Weighted average by Cap. | +0.67% | +1.41% | +34.69% | +61.05% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 15.7M 13.68M 12.95M 11.76M 21.97M 1.5B 22.08M 154M 59.63M 764M 59M 57.68M 2.45B | 13.79M 12.01M 11.37M 10.33M 19.29M 1.32B 19.39M 135M 52.35M 671M 51.8M 50.65M 2.15B |
| Net income | -2.39M -2.09M -1.97M -1.79M -3.35M -229M -3.37M -23.51M -9.09M -117M -8.99M -8.79M -373M | -958K -834K -790K -718K -1.34M -91.75M -1.35M -9.41M -3.64M -46.63M -3.6M -3.52M -149M |
| Net Debt | 325K 283K 268K 243K 455K 31.13M 457K 3.19M 1.23M 15.82M 1.22M 1.19M 50.64M | 1.72M 1.5M 1.42M 1.29M 2.4M 165M 2.42M 16.87M 6.52M 83.62M 6.45M 6.31M 268M |
Employees
-
Sector
Pharmaceuticals
Select your edition
All financial news and data tailored to specific country editions
















